Shire competitorsClear all

Shire's top competitors include Pfizer, Celgene, Amgen, Vertex Pharmaceuticals, Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceuticals, Biogen and Sanofi Genzyme.
Shire
Shire
Shire is a specialty biopharmaceutical company.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
Celgene
Celgene
Celgene Corporation is a biopharmaceutical company.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Alexion Pharmaceuticals
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines for the treatment of eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Sanofi Genzyme
Sanofi Genzyme
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
Founding Date
Founding Date
1986
Founding Date
1849
Founding Date
1986
Founding Date
1980
Founding Date
1989
Founding Date
1987
Founding Date
1992
Founding Date
1988
Founding Date
1978
Founding Date
1981
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Dublin, IE HQ
The Rocks, AU
Wien, AT
Bruxelles, BE
Sofia, BG
see more
Locations
New York, US HQ
Melrose Park, AU
Wien, AT
Minsk, BY
Ixelles, BE
Sofia, BG
Kirkland, CA
see more
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Diegem, BE
see more
Locations
Boston, US HQ
St Leonards, AU
Wien, AT
Toronto, CA
see more
Locations
Foster City, US HQ
Melbourne, AU
København, DK
Hod Hasharon, IL
Milano, IT
Warszawa, PL
Dubai, AE
see more
Locations
New Haven, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
São Paulo, BR
Toronto, CA
Prague, CZ
see more
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Greater London, GB
Bernards, US
Rensselaer, US
Washington, US
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Cambridge, US HQ
Employees
Employees
N/A
Employees
88,3004% decrease
Employees
N/A
Employees
23,4009% increase
Employees
3,00020% increase
Employees
11,8007% increase
Employees
2,6565% increase
Employees
8,1009% increase
Employees
7,4005% decrease
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
199.9 b
Valuation ($)
N/A
Valuation ($)
132.7 b
Valuation ($)
68.9 b
Valuation ($)
96.3 b
Valuation ($)
25.4 b
Valuation ($)
61.3 b
Valuation ($)
50.1 b
Valuation ($)
N/A
Twitter followers
Twitter followers
7.7 k
Twitter followers
18.4 k
Twitter followers
26.8 k
Twitter followers
89.4 k
Twitter followers
64.3 k
Twitter followers
60.7 k
Twitter followers
5 k
Twitter followers
21.3 k
Twitter followers
32 k
Twitter followers
56.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
72
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
33
Number of tweets (last 30 days)
26
Number of tweets (last 30 days)
36
Number of tweets (last 30 days)
72
Number of tweets (last 30 days)
30
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
12.3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
21.3
Average likes per tweet (last 30 days)
15.3
Average likes per tweet (last 30 days)
69.6
Average likes per tweet (last 30 days)
7.6
Average likes per tweet (last 30 days)
16.6
Average likes per tweet (last 30 days)
34.4
Average likes per tweet (last 30 days)
12.2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
93.06%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
96.97%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
97.22%
Percentage of tweets with engagement (last 30 days)
95.83%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
216122
Alexa Website Rank
33164
Alexa Website Rank
274765
Alexa Website Rank
173418
Alexa Website Rank
191230
Alexa Website Rank
72595
Alexa Website Rank
332308
Alexa Website Rank
306920
Alexa Website Rank
222327
Alexa Website Rank
320934
Employee Rating
Employee Rating
3.0
Employee Rating
4.1
Employee Rating
4.0
Employee Rating
3.8
Employee Rating
3.3
Employee Rating
3.4
Employee Rating
N/A
Employee Rating
3.9
Employee Rating
3.5
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
£43m (FY, 2018)
Revenue (est.)
$51.8b (FY, 2019)
Revenue (est.)
$15.3b (FY, 2018)
Revenue (est.)
$23.4b (FY, 2019)
Revenue (est.)
$4.2b (FY, 2019)
Revenue (est.)
$22.4b (FY, 2019)
Revenue (est.)
$5b (FY, 2019)
Revenue (est.)
$7.9b (FY, 2019)
Revenue (est.)
$14.4b (FY, 2019)
Revenue (est.)
$5b (Y, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$10.2b (FY, 2019)
Cost of goods
$587m (FY, 2018)
Cost of goods
$4.4b (FY, 2019)
Cost of goods
$547.8m (FY, 2019)
Cost of goods
$4.7b (FY, 2019)
Cost of goods
$394.5m (FY, 2019)
Cost of goods
$782.2m (FY, 2019)
Cost of goods
$2b (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$41.5b (FY, 2019)
Gross profit
$14.7b (FY, 2018)
Gross profit
$19b (FY, 2019)
Gross profit
$3.6b (FY, 2019)
Gross profit
$17.8b (FY, 2019)
Gross profit
$4.6b (FY, 2019)
Gross profit
$7.1b (FY, 2019)
Gross profit
$12.4b (FY, 2019)
Gross profit
N/A
Net income
Net income
£3.4m (FY, 2018)
Net income
$16.3b (FY, 2019)
Net income
$4b (FY, 2018)
Net income
$7.8b (FY, 2019)
Net income
$1.2b (FY, 2019)
Net income
$5.4b (FY, 2019)
Net income
$2.4b (FY, 2019)
Net income
$2.1b (FY, 2019)
Net income
$5.9b (FY, 2019)
Net income
N/A

Operating

Active Clinical Studies
Active Clinical Studies
N/A
Active Clinical Studies
338 (FY, 2015)
Active Clinical Studies
52 (FY, 2016)
Active Clinical Studies
N/A
Active Clinical Studies
N/A
Active Clinical Studies
N/A
Active Clinical Studies
N/A
Active Clinical Studies
N/A
Active Clinical Studies
N/A
Active Clinical Studies
N/A
Countries
Countries
100 (FY, 2017)
Countries
125 (FY, 2017)
Countries
N/A
Countries
100 (FY, 2019)
Countries
N/A
Countries
35 (FY, 2019)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
100 (Sep, 2018)
Manufacturing Sites
Manufacturing Sites
14 (FY, 2017)
Manufacturing Sites
58 (FY, 2017)
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Patents (EU)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
21 (FY, 2019)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
11 (FY, 2019)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
34 (FY, 2019)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
21 (FY, 2019)
Patents (US)
21 (FY, 2019)
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
22 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
9 (FY, 2019)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
11 (FY, 2019)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
29 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
14 (Feb, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
6 (FY, 2019)
Phase III Trials Products
N/A
Products
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
24 (FY, 2019)
Products
N/A
Products
7 (FY, 2019)
Products
N/A
Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
$ 2.4m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 8.9m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Pfizer
HQ
New York, US
Employees
88,300↓ 4% decrease

Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.

View company
Celgene
HQ
Summit, US

Celgene Corporation is a biopharmaceutical company.

View company
Amgen
HQ
Thousand Oaks, US
Employees
23,400↑ 9% increase

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company
Vertex Pharmaceuticals
HQ
Boston, US
Employees
3,000↑ 20% increase

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

View company